These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7046773)

  • 1. Response of the systemic pulmonary circulation to labetalol at rest and during exercise.
    Fagard R; Lijnen P; Amery A
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):13S-17S. PubMed ID: 7046773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of labetalol on systemic and pulmonary haemodynamics at rest and during exercise in hypertensive patients.
    Fagard R; Amery A; Reybrouck T; Lijnen P; Billiet L
    Clin Sci Mol Med Suppl; 1978 Dec; 4():279s-281s. PubMed ID: 282068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hemodynamic effects of an alpha- and beta-receptor blocking agent (AH 5158) on the systemic and pulmonary circulation at rest and during exercise in hypertensive patients.
    Koch G
    Am Heart J; 1977 May; 93(5):585-91. PubMed ID: 851058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of labetalol on plasma renin, aldosterone, and catecholamines in hypertensive patients.
    Lijnen PJ; Amery AK; Fagard RH; Reybrouck TM; Moerman EJ; De Schaepdryver AF
    J Cardiovasc Pharmacol; 1979; 1(6):625-32. PubMed ID: 94628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P
    Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
    Koch G
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential haemodynamic effects of labetalol at rest and during exercise in essential hypertension.
    Svendsen TL; Rasmussen S; Hartling OJ; Nielsen PE; Trap-Jensen J
    Postgrad Med J; 1980; 56 Suppl 2():21-6. PubMed ID: 7433338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
    Lammintausta R; Koulu M; Allonen H
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):240-43. PubMed ID: 38214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic effects of long-term oral labetalol.
    Edwards RC; Raftery EB
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative haemodynamic dose response effects of propranolol and labetalol in coronary heart disease.
    Silke B; Nelson GI; Ahuja RC; Taylor SH
    Br Heart J; 1982 Oct; 48(4):364-71. PubMed ID: 7126388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular dynamics after acute and long-term alpha- and beta-adrenoceptor blockade at rest, supine and standing, and during exercise.
    Koch G
    Br J Clin Pharmacol; 1979; 8(Suppl 2):101S-105S. PubMed ID: 43162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate effects of labetalol on central, splanchnic-hepatic, and forearm haemodynamics during pleasant emotional stress in hypertensive patients.
    Trap-Jensen J; Clausen JP; Hartling OJ; Svendsen TL; Krogsgaard AR
    Postgrad Med J; 1980; 56 Suppl 2():37-42. PubMed ID: 7433341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the haemodynamic effects of labetalol in man.
    Cohn JN; Mehta J; Francis GS
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):19S-26S. PubMed ID: 7093099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and long-term effects of labetalol on systemic and pulmonary haemodynamics in hypertensive patients.
    Svendsen TL; Rasmussen S; Hartling OJ; Nielsen PE; Trap-Jensen J
    Eur J Clin Pharmacol; 1980 Jan; 17(1):5-11. PubMed ID: 7371699
    [No Abstract]   [Full Text] [Related]  

  • 15. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
    Martinand A; Lardoux H; Corvol P; Milliez P
    Nouv Presse Med; 1980 Sep; 9(35):2565-8. PubMed ID: 7001349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
    Mehta J; Cohn JN
    Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of labetalol on plasma catecholamines at rest and during increased sympathetic activity.
    Carlsen JE; Trap-Jensen J; Svendsen TL; Nielsen PE; Rasmussen S; Christensen NJ
    Postgrad Med J; 1980; 56 Suppl 2():43-8. PubMed ID: 7433342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic effects of labetalol-induced hypotension in the anaesthetized dog.
    Gustafson C; Ahlgren I; Aronsen KF; Rosberg B
    Br J Anaesth; 1981 Jun; 53(6):585-90. PubMed ID: 7248122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.
    Larsen JS; Pedersen EB
    Eur J Clin Pharmacol; 1980 Aug; 18(2):135-9. PubMed ID: 7428793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral labetalol on plasma catecholamines, renin and aldosterone in patients with severe arterial hypertension.
    Kornerup HJ; Pedersen EB; Christensen NJ; Pedersen A; Pedersen G
    Eur J Clin Pharmacol; 1979 Nov; 16(5):305-10. PubMed ID: 520398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.